News

As Seen In
Regenerative medicine: Interview with a game-changing leader
8 years ago Sep 20, 2017
Regenerative medicine is a game-changing area of medicine. It has the potential to fully heal...
Press Release
RepliCel’s Partnership Initiatives Mature into Licensing Negotiations
8 years ago Sep 12, 2017
Due diligence and confidential discussions now moving into negotiations for products in both the tendon...
Press Release
RepliCel Showcases First Fully-Functional Prototypes of its Next-Generation Dermal Injector
8 years ago Sep 06, 2017
Delivery of RepliCel’s patented prototypes kick-starts functional testing, matures licensing discussions, and confirms commercialization scheduleVANCOUVER,...
As Seen In
Analyst Says Cell Therapy Company’s Move Decreases Risk
8 years ago Aug 24, 2017
Click here to read the full article as it appears in the Streetwise Reports (08/23/17)....
As Seen In
Your Hair Follicles May Hold the Key to Younger Looking Skin
8 years ago Aug 24, 2017
Click here to read the full article as it appears in the New York Daily...
Press Release
RepliCel Life Sciences Joins MedCision’s ThawSTAR® Early Adopter Program
8 years ago Aug 15, 2017
Regenerative Medicine Company to Adopt ThawSTAR® Cell Thawing Systems to De-Risk Cell Therapy Clinical TrialVANCOUVER,...
Press Release
Prominent Skin Aging Researcher Provides Insights into RepliCel’s Clinical Data
8 years ago Aug 09, 2017
“We believe that this novel therapy has the potential to rejuvenate skin in a way...
As Seen In
Skin in the Game
8 years ago Aug 08, 2017
To read the full article as it appears on DDN News (08/08/17), click here. ...
As Seen In
Why RepliCel May Be the Most Compelling Biotech Company to Watch in Canada
8 years ago Jul 30, 2017
To read the brief and watch the interview provided by Market One Media Group as...
As Seen In
RepliCel Poised To Partner Up For Precision-Control Dermal Injector
8 years ago Jul 22, 2017
To preview the interview with Tina Tan as it appears on Medtech.com, click here. (6/23/17)
As Seen In
Hair-Raising R&D: RepliCel Developing Autologous Cell Therapy for Baldness
8 years ago Jul 13, 2017
To read the full article as it appears on BioPharma-reporter.com, click here. (7/12/17) ...
As Seen In
Poised for Success with Positive Clinical Results
8 years ago Jul 05, 2017
To read the full interview as it appears on Costmeticosbr.com.br, click here (7/6/17).
As Seen In
A New Approach to Treating Hair Loss
8 years ago Jun 26, 2017
To read the full interview as it appears on Technologyworks.com, click here. (6/27/17)
As Seen In
Your Hair Could Hold The Secret To Mending Your Injured Tendon
8 years ago Jun 26, 2017
To read the full article as it appears on Pridenews.ca , click here (6/27/17)....
As Seen In
The Latest in Biocellular Regeneration
8 years ago Jun 19, 2017
To read the full article as it appears on TheAestheticChannel.com by Lisette Hilton, click here...
Press Release
RepliCel Collaborates with University of British Columbia to Build World-Class Hair Follicle Cell Data Map
8 years ago Jun 12, 2017
Data from this project expected to take RepliCel’s products to next level of potential commercial...
As Seen In
Pioneer in Both Biotech & Business Left Noteworthy Legacy
8 years ago Jun 08, 2017
To read the full article as it appears on HuffingtonPost.com by contributing editor, Lee Buckler,...
As Seen In
Exclusive Interview with RepliCel Life Sciences President and CEO Lee Buckler
8 years ago Jun 07, 2017
To read the full article as it appears on SmarterAnalyst.com by Julie Lamb, click here....
As Seen In
Promise of Regenerative Medicine Already Upon Us
8 years ago Jun 05, 2017
To read the full article as it appears on HuffingtonPost.com by contributing editor, Lee Buckler,...
As Seen In
RepliCel Life Sciences gets price target raise at Echelon Wealth Partners
8 years ago May 29, 2017
To read the full article as it appears on Cantech Letters by Nick Waddell, click...

by Type

by Topic

by month

DISCLAIMER:
The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, RepliCel Life Sciences Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.

THIRD PARTY CONTENT
Please note that any opinion, estimates or forecasts made by the authors of these statements are theirs alone and do not represent opinions, forecasts or predictions of RepliCel Life Sciences Inc. or its management. RepliCel Life Sciences Inc. does not, by its reference or distribution of these links imply its endorsement of, or concurrence with, such information, conclusions or recommendations.